Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Stockholders' Equity (Deficit)

v3.22.4
Consolidated Statements of Stockholders' Equity (Deficit) - USD ($)
Total
Common Stock [Member]
Additional Paid-In Capital [Member]
Treasury Stock [Member]
Accumulated Deficit [Member]
Beginning balance at Nov. 30, 2020 $ (2,665,135) $ 136,336 $ 36,581,600 $ (20,563,357) $ (18,819,714)
Beginning balance, shares at Nov. 30, 2020   13,633,638      
Exercise of stock options 1,128,517 $ 6,224 1,122,293    
Exercise of stock options, shares   622,400      
Common stock issued to Duke 3,585,172 $ 4,098 3,581,074    
Common stock issued to Duke, shares   409,734      
Compensatory element of stock options 301,616   301,616    
Treasury stock (249,377)     (249,377)  
Net income 2,083,521       2,083,521
Ending balance at Nov. 30, 2021 4,184,314 $ 146,658 41,586,583 (20,812,734) (16,736,193)
Ending balance, shares at Nov. 30, 2021   14,665,772      
Exercise of stock options 551,274 $ 1,822 549,452    
Exercise of stock options, shares   182,229      
Compensatory element of stock options 461,345   461,345    
Treasury stock (1,819,915)     (1,819,915)  
Dividends declared ($0.90 per share) (7,672,728)       (7,672,728)
Net income 2,771,408       2,771,408
Ending balance at Nov. 30, 2022 $ (1,524,302) $ 148,480 $ 42,597,380 $ (22,632,649) $ (21,637,513)
Ending balance, shares at Nov. 30, 2022   14,848,001